| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ernexa Therapeutics Inc. (ERNA) has 0 insiders with recent SEC Form 4 filings, including 14 buys and 17 sells. ERNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2017 | Awm Investment Company, Inc.73 | 10% Owner | Sell | 2,300 | $7.42 | $17,073.92 | -0.2% | |
| Aug 25, 2017 | Awm Investment Company, Inc.73 | 10% Owner | Sell | 2,566 | $7.48 | $19,205.04 | -0.4% | |
| Aug 22, 2017 | Awm Investment Company, Inc.73 | 10% Owner | Sell | 458 | $7.84 | $3,590.79 | - | |
| Aug 17, 2017 | Awm Investment Company, Inc.73 | 10% Owner | Sell | 755 | $7.56 | $5,711.25 | - | |
| Aug 11, 2017 | Awm Investment Company, Inc.73 | 10% Owner | Sell | 6,093 | $7.52 | $45,789.50 | -1.9% | |
| Dec 30, 2016 | Awm Investment Company, Inc.73 | 10% Owner | Sell | 2,310 | $8.50 | $19,635.00 | -0.7% | |
| Dec 27, 2016 | Awm Investment Company, Inc.73 | 10% Owner | Sell | 5,752 | $8.84 | $50,837.67 | -0.4% | |
| Nov 16, 2016 | Berg Jeffrey Alan | Director, 10% Owner | Buy | 5,620 | $7.24 | $40,679.20 | +0.2% | |
| Aug 12, 2016 | Berg Jeffrey Alan | Director, 10% Owner | Buy | 4,000 | $5.37 | $21,480.00 | +0.2% | |
| Jun 17, 2016 | Miller Dave Brian | SVP Marketing | Buy | 2,000 | $4.75 | $9,508.30 | +15.0% |